Dengue is a mosquito-borne viral disease widely spread in tropical and subtropical regions. It is transmitted by Aedes mosquitoes. Most of the clinical cases present a febrile illness, severe forms include hemorrhagic fevers and shock with fatalities.
Since the beginning of 2024, over 10 million dengue cases and over 5 000 dengue-related deaths have been reported from 80 countries/territories. Most cases globally have been reported from the WHO PAHO region.
Every month ECDC provides detailed epidemiological overview of the worldwide transmission of dengue in its weekly threat report (Communicable Diseases Threat Report).
Since the beginning of 2024, over 7.5 million dengue cases and over 3 000 dengue-related deaths have been reported from 73 countries/territories. Most cases globally have been reported from the WHO PAHO region, with Brazil reporting most cases.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 13-19 July 2024 and includes updates on influenza A(H5N1), Measles, Overview of respiratory virus epidemiology in the EU/EEA, ), Cholera, Seasonal surveillance of West Nile virus infections and Mass gathering monitoring.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 20 - 26 July and includes updates on Avian influenza A(H5N6), SARS-CoV-2 variant classification, Overview of respiratory virus epidemiology in the EU/EEA, Circulating vaccine-derived poliovirus type 2 (cVDPV2), cholera, Crimean-Congo haemorrhagic fever, Oropouche virus disease, Seasonal surveillance of West Nile virus infections, Mass gathering monitoring - Olympic and Paralympic Games, Nipah virus disease.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 6–12 July 2024 and includes updates on imported Oropouche human infections, Seasonal surveillance of West Nile virus infections, Locally acquired dengue, Yersinia enterocolitica, Cholera, Overview of respiratory virus epidemiology in the EU/EEA, Influenza A(H5N1), Mass gathering monitoring, Mpox and Middle Eastern Respiratory Syndrome (MERS).